Mechanisms of escape from CD8+ T-cell clones specific for the HER-2/neu proto-oncogene expressed in ovarian carcinomas: Related and unrelated to decreased MHC class 1 expression

International Journal of Cancer

Volumn 70, Issue 1, 1997, Pages 112-119

  Kono, Koji ^a   Halapi, Eva ^a   Hising, Christina ^b   Petersson, Max ^a   Gerdin, Eva ^c   Vanky, Farkas ^a,b   Kiessling, Rolf ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CELL ADHESION MOLECULE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; ONCOGENE NEU; OVARY CARCINOMA; PRIORITY JOURNAL; PROTO ONCOGENE; T LYMPHOCYTE;

DOWN-REGULATION; FEMALE; HLA-A2 ANTIGEN; HUMANS; IMMUNOLOGIC SURVEILLANCE; OVARIAN NEOPLASMS; RECEPTOR, ERBB-2; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 0031018215     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970106)70:1<112::AID-IJC17>3.0.CO;2-N     Document Type: Article

References (24)

1. BODMER, W.F., BROWNING, M.J., KRAUSA, P., ROWAN, A., BICKNELL, D.C. and BODMER, J.G., Tumor escape from immune response by variation in HLA expression and other mechanisms. Ann. N.Y. Acad. Sci., 690, 42-49 (1993).
2. COUSSENS, L., YANG-FENG, L., LIAO, Y.C., CHEN, E., GRAY, A., MCGRATH, J., SEEBURG, P.H., LIBERMANN, T.A., SCHLESSINGER, J., FRANCKE, U., LEVINSON, A. and ULLRICH, A., Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science, 230, 1132-1136 (1985).
3. COX, A.L., SKIPPER, J., CHEN, Y., HENDERSON, R.A., DARROWS, T.L., HABANOWITZ, J., ENGELHARD, V.H., HUNT, D.F. and SLINGLUFF, C.L., Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science, 264, 716-719 (1994).
4. FISK, B., BLEVINS, T.L., WHARTON, J.T. and IOANNIDES, C.G., Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte line. J. exp. Med., 181, 2109-2117 (1995).
5. GATTONI-CELLI, S., KIRSCH, K., TIMPANE, R. and ISSELBACHER, K.J., β2-Microglobulin gene is mutated in a human colon cancer line (HCT) deficient in the expression of HLA class I antigens on the cell surface. Cancer Res., 52, 1201-1204 (1992).
6. HANSEN, M.B., NIELSEN, S.E. and BERK, K., Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. immunol. Methods, 119, 203-210 (1989).
7. HULTMAN, T., STÅHL, S., HORNES, E. and ÚHLEN, M., Direct solid phase sequencing of genomic and plasmid DNA using magnetic beads as solid support. Nucleic Acids Res., 17, 4937-4946 (1989).
8. IOANNIDES, C.G., FREEDMAN, R.S., PLATSOUCAS, C.D., HASHED, S. and KIM, Y.P., Cytotoxic T cell clones isolated from ovarian tumor-infiltrating lymphocytes recognized multiple antigenic epitopes on autologous tumor cells. J. Immunol., 146, 1700-1707 (1991).
9. KAKLAMANIS, L., RUSSELL, L., KOUKOURAKIS, M., GATTER, K.C. and HARRIS, A.L., Loss of transporter in antigen processing 1 transport protein and major histocompatibility complex class I molecules in metastatic versus primary breast cancer. Cancer Res., 55, 5191-5194 (1995).
10. LINEHAN, D.C., GOEDEGEBUURE, P.S., PEOPLE, G.E., ROGERS, S.O. and EBERLEIN, T.J., Tumor-specific and HLA-A2-restricted cytolysis by tumor-associated lymphocytes in human metastatic breast cancer. J. Immunol., 155, 4486-4491 (1995).
11. MARINCOLA, F.M. and 12 OTHERS, Loss of HLA haplotype and B locus down-regulation in melanoma cell lines. J. Immunol., 153, 1225-1237 (1994).
12. MAYORDOMO, J.I., ZORINA, T., STORKUS, W.J., ZITVOGEL, L., CELLUZZI, C., FALO, L.D., MELIEF, C.J., ILDSTAD, S.T., MARTIN KAST, W., DE LEO, A.B. and LOTZE, M.T., Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nature (Med.), 1, 1297-1302 (1995).
13. NIEHANS, G.A., SINGLETON, T.P., DYKOSKI, D. and KIANG, D.T., Stability of HER-2/neu expression over time and at multiple metastatic sites. J. nat. Cancer Inst., 85, 1230-1235 (1993).
14. PHOPLE, G.E., GOEDEGEBUURE, P.S., ANDREWS, J.V.R., SCHOOF, D.D. and EBERLEIN, T.J., HLA-A2 presents shared tumor-associated antigens derived from endogenous proteins in ovarian cancer. J. Immunol., 151, 5481-5491 (1993).
15. RESTIFO, N.P., ESQUIVEL, F., KAWAKAMI, Y., YEWDELL, J.W., MULE, J.J., ROSENBERG, S.A. and BENNINK, J.R., Identification of human cancers deficient in antigen processing. J. exp. Med., 177, 265-272 (1993).
16. RIVOLTINI, L., BARRACCHINI, K.C., VIGGIANO, V., KAWAKAMI, Y., SMITH, A., MIXON, A., RESTIFO, N.P., TOPALIAN, L., SIMONIS, T.B., ROSENBERG, S.A. and MARINCOLA, F.M., Quantitative correlation between HLA class I allele expression and recognition of melanoma cells by antigen-specific cytotoxic T lymphocytes. Cancer Res., 55, 3149-3157 (1995).
17. ROSENBERG, S.A. and 15 OTHERS, Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. N. Engl. J. Med., 319, 1676-1680 (1988).
18. RUNGER, T.M., KLEIN, C.E., BECKER, J.C. and BROCKER, E.B., The role of genetic instability, adhesion, cell motility, and immune escape mechanisms in melanoma progression. Curr. Opin. Oncol., 6, 188-196 (1994).
19. SLAMON, D.J., GODOLPHIN, W., JONES, L.A., HOLT, J.A., WONG, S.G., KEITH, D.E., LEVIN, W.J., STUART, S.G., UDOVE, J., ULLRICH, A. and PRESS, M.F., Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science, 244, 707-712 (1989).
20. UYTTENHOVE, C., MARYANSKI, J. and BOON, T., Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen-loss variants rather than immunosuppression. J. exp. Med., 157, 1040-1052 (1983).
21. VAN DEN EYNDE, B., HAINAUT, P., HÉRIN, M., KNUTH, A., LEMOINE, C., WEYNANTS, P., VAN DER BRUGGEN, P., FAUCHET, R. and BOON, T., Presence on a human melanoma of multiple antigens recognized by autologous CTL. Int. J. Cancer, 44, 630-640 (1989).
22. VAN DER BRUGGEN, P., TRAVERSARI, C., CHOMEZ, P., LOCQUIN, C., DE PLAEN, E., VAN DEN EYNDE, B., KNUTH, A. and BOON, T., A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science, 254, 1643-1647 (1991).
23. YOSHINO, I., GOEDEGEBUURE, P.S., PEOPLE, G.E., PARIKH, A.S., DI MAIO, J.M., LYERLY, H.K., GAZDAR, A.F. and EBERLEIN, T.J., HER-2/new-derived peptides are shared antigens among human non-small cell lung cancer and ovarian cancer. Cancer Res., 54, 3387-3390 (1994a).
24. YOSHINO, I., PEOPLE, G.E., GOEDEGEBUURE, P.S., MAZIARZ, R. and EBERLEIN, T.J., Association of HER-2/neu expression with sensitivity to tumor-specific CTL in human ovarian cancer. J. Immunol., 152, 2393-2400 (1994b).